| scholarly article | Q13442814 |
| P50 | author | Joachim Yahalom | Q50056528 |
| Lois B. Travis | Q91794501 | ||
| Ching-Hon Pui | Q66385450 | ||
| P2093 | author name string | X George Xu | |
| James M Allan | |||
| Ann R Kennedy | |||
| John D Boice | |||
| Louis S Constine | |||
| Kimberly Applegate | |||
| Andrea K Ng | |||
| James A Purdy | |||
| Ethel S Gilbert | |||
| P2860 | cites work | Lung cancer after treatment for Hodgkin's disease: focus on radiation effects | Q43853157 |
| Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease | Q43878525 | ||
| Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983. | Q44054492 | ||
| Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer | Q44412508 | ||
| Radiation therapy and late mortality from second sarcoma, carcinoma, and hematological malignancies after a solid cancer in childhood | Q44482589 | ||
| Second cancers among long-term survivors of non-Hodgkin's lymphoma | Q44576715 | ||
| Cardiac risk after mediastinal irradiation for Hodgkin's disease | Q44682951 | ||
| Hodgkin's disease following non-Hodgkin's lymphoma | Q44963781 | ||
| Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers | Q45103435 | ||
| The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06. | Q45282020 | ||
| Therapy-induced malignant neoplasms in Nf1 mutant mice. | Q46001683 | ||
| Diastolic dysfunction after mediastinal irradiation | Q46145721 | ||
| Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer | Q46317196 | ||
| The codon 47 polymorphism in p53 is functionally significant. | Q46455258 | ||
| Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study. | Q46758819 | ||
| Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients | Q46838211 | ||
| Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy | Q47340813 | ||
| Constrictive pericarditis in the modern era: evolving clinical spectrum and impact on outcome after pericardiectomy | Q47701469 | ||
| Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease | Q47788586 | ||
| Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. | Q47949009 | ||
| Is there an increased risk of second primaries following prostate irradiation? | Q48025597 | ||
| High incidence of secondary brain tumours after radiotherapy and antimetabolites. | Q48163138 | ||
| Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital | Q48331162 | ||
| Risks of brain tumour following treatment for cancer in childhood: modification by genetic factors, radiotherapy and chemotherapy | Q48378119 | ||
| New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. | Q48381836 | ||
| TGFbeta1 polymorphisms and late clinical radiosensitivity in patients treated for gynecologic tumors. | Q49080982 | ||
| Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danis | Q50564769 | ||
| Twenty-year incidence and patterns of contralateral breast cancer after breast conservation treatment with radiation. | Q50789653 | ||
| Potential etiologic and functional implications of genome-wide association loci for human diseases and traits | Q22066284 | ||
| Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variants | Q24624194 | ||
| Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma | Q24632704 | ||
| Treating childhood acute lymphoblastic leukemia without cranial irradiation | Q24644599 | ||
| Intensity-modulated radiotherapy: current status and issues of interest | Q28204767 | ||
| Leukemia following Hodgkin's disease | Q28298508 | ||
| Polymorphisms in oxidative stress and inflammation pathway genes, low-dose ionizing radiation, and the risk of breast cancer among US radiologic technologists | Q28387859 | ||
| Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study | Q30432746 | ||
| Cancer incidence after localized therapy for prostate cancer | Q30441150 | ||
| Associated cardiac lesions in patients with radiation-induced complete heart block | Q33174362 | ||
| Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study | Q33262846 | ||
| Genetic predictors of long-term toxicities after radiation therapy for breast cancer | Q33306558 | ||
| Second primary cancer risk of radiation therapy after radical prostatectomy for prostate cancer: an analysis of SEER data | Q33486265 | ||
| Cardiotoxicity of cancer therapy | Q33704056 | ||
| Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's disease | Q33773312 | ||
| A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases | Q33789567 | ||
| Polymorphisms in estrogen biosynthesis and metabolism-related genes, ionizing radiation exposure, and risk of breast cancer among US radiologic technologists | Q33813463 | ||
| Radiation carcinogenesis | Q33846192 | ||
| Thyroid nodules, polymorphic variants in DNA repair and RET-related genes, and interaction with ionizing radiation exposure from nuclear tests in Kazakhstan | Q33873811 | ||
| Secondary malignant neoplasms after Wilms tumor: an international collaborative study. | Q33886717 | ||
| Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery | Q33887078 | ||
| Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group | Q33903257 | ||
| Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation | Q33927551 | ||
| The stereotaxic method and radiosurgery of the brain. | Q33975919 | ||
| Mouse models for the p53 R72P polymorphism mimic human phenotypes | Q34001196 | ||
| Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study | Q34008980 | ||
| Testicular cancer survivorship: research strategies and recommendations | Q34039684 | ||
| Novel breast cancer risk alleles and interaction with ionizing radiation among U.S. radiologic technologists | Q34070675 | ||
| Establishment of a Radiogenomics Consortium | Q34106703 | ||
| Elevated lung cancer risk is associated with deficiencies in cell cycle checkpoints: genotype and phenotype analyses from a case-control study | Q34175342 | ||
| A patient with 17 primary tumours and a germ line mutation in TP53: tumour induction by adjuvant therapy? | Q34227467 | ||
| Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up | Q34407554 | ||
| Radiation dose and breast cancer risk in the childhood cancer survivor study | Q37324982 | ||
| Risk of cerebrovascular events after neck and supraclavicular radiotherapy: a systematic review | Q37378188 | ||
| Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy | Q37408593 | ||
| Management of stage I seminomatous testicular cancer: a systematic review. | Q37602353 | ||
| Factors that modify radiation-induced carcinogenesis | Q37612760 | ||
| Does scientific evidence support a change from the LNT model for low-dose radiation risk extrapolation? | Q37612768 | ||
| Radiation-associated valvular disease | Q37642314 | ||
| Nucleotide excision repair polymorphisms may modify ionizing radiation-related breast cancer risk in US radiologic technologists | Q37700040 | ||
| Uncovering the roles of rare variants in common disease through whole-genome sequencing | Q37755970 | ||
| Assessment of coronary heart disease morbidity and mortality after radiation therapy for early breast cancer | Q38436207 | ||
| Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma | Q38471731 | ||
| Radiation dose and leukemia risk in patients treated for cancer of the cervix | Q38518796 | ||
| Acute normal tissue reactions in head-and-neck cancer patients treated with IMRT: influence of dose and association with genetic polymorphisms in DNA DSB repair genes. | Q38551281 | ||
| Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment | Q39501899 | ||
| C-reactive protein; a potential marker of second cancer and cardiovascular disease in testicular cancer survivors? | Q39838882 | ||
| Radiation-induced valvular disease is the logical consequence of irradiation | Q40221945 | ||
| Radiation injury to the heart | Q40505512 | ||
| Functional consequences of ATM sequence variants for chromosomal radiosensitivity | Q40564238 | ||
| ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity | Q40604137 | ||
| Second malignancy after treatment of childhood acute myeloid leukemia. | Q40720181 | ||
| Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma | Q40733712 | ||
| Modulation of patched-associated susceptibility to radiation induced tumorigenesis by genetic background | Q42462453 | ||
| High incidence of meningioma in cranial irradiated survivors of childhood acute lymphoblastic leukemia. | Q42507220 | ||
| Sinonasal carcinoma after irradiation for medulloblastoma in nevoid basal cell carcinoma syndrome | Q42518512 | ||
| Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for hodgkin disease in children and adolescents: Report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies | Q42928144 | ||
| Long-term results of Dutch Childhood Oncology Group studies for children with acute lymphoblastic leukemia from 1984 to 2004. | Q43217994 | ||
| Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy | Q43237206 | ||
| Lung cancer susceptibility among atomic bomb survivors in relation to CA repeat number polymorphism of epidermal growth factor receptor gene and radiation dose | Q43258122 | ||
| Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment | Q43543604 | ||
| Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger | Q43673371 | ||
| Secondary neoplasms subsequent to Berlin-Frankfurt-Münster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy | Q73708445 | ||
| Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study | Q73774006 | ||
| Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia | Q73806341 | ||
| Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors | Q74675998 | ||
| The risk of second malignancy in men with prostate cancer treated with or without radiation in British Columbia, 1984-2000 | Q78607881 | ||
| Late cardiotoxicity after treatment for Hodgkin lymphoma | Q79374548 | ||
| A population-based case-cohort study of the risk of myocardial infarction following radiation therapy for breast cancer | Q79717090 | ||
| Risks for familial and contralateral breast cancer interact multiplicatively and cause a high risk | Q79730895 | ||
| Therapeutic radiation for lymphoma: risk of malignant mesothelioma | Q79812038 | ||
| Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor | Q79844469 | ||
| Long-term risk of cardiovascular disease in 10-year survivors of breast cancer | Q79887212 | ||
| Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients | Q80341012 | ||
| Cardiotoxic effects of tangential breast irradiation in early breast cancer patients: the role of irradiated heart volume | Q80556884 | ||
| Radiation therapy in Hodgkin disease: why risk a Pyrrhic victory? | Q81309494 | ||
| Increased risk of squamous cell esophageal cancer after adjuvant radiation therapy for primary breast cancer | Q81363028 | ||
| Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer | Q81530165 | ||
| Cancer survivorship research: opportunities and future needs for expanding the research base | Q81643933 | ||
| Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma | Q84080334 | ||
| Long-term cause-specific mortality among survivors of childhood cancer | Q84565844 | ||
| Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers | Q84786183 | ||
| Cerebral radiosurgery. I. Gammathalanotomy in two cases of intractable pain | Q51193677 | ||
| Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes. | Q51621180 | ||
| Myelodysplastic syndromes arising in patients with germline TP53 mutation and Li-Fraumeni syndrome. | Q51764397 | ||
| Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group. | Q51798328 | ||
| The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma. | Q51804623 | ||
| Prostatic irradiation is not associated with any measurable increase in the risk of subsequent rectal cancer. | Q51945506 | ||
| Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. | Q53256330 | ||
| Induction and prevention of carcinogenesis in rat skin exposed to space radiation. | Q53335278 | ||
| Impact of ionizing radiation and genetic background on mammary tumorigenesis in p53-deficient mice. | Q53396179 | ||
| Two metachronous tumors in the radiotherapy fields of a patient with Li-Fraumeni syndrome. | Q53396938 | ||
| Radiation dose and second cancer risk in patients treated for cancer of the cervix. | Q53413561 | ||
| Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma. | Q53456824 | ||
| Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease. | Q53460488 | ||
| The incidence and functional consequences of RT-associated cardiac perfusion defects. | Q53573289 | ||
| Risk of second malignant neoplasms among lymphoma patients with a family history of cancer. | Q53586102 | ||
| Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. | Q53640113 | ||
| Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study. | Q53671338 | ||
| ATM polymorphisms are associated with risk of radiation-induced pneumonitis. | Q54691265 | ||
| Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy. | Q55470115 | ||
| Linking DNA damage to medulloblastoma tumorigenesis in patched heterozygous knockout mice. | Q55470661 | ||
| Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancers | Q56928442 | ||
| Polymorphisms in DNA repair genes, ionizing radiation exposure and risk of breast cancer in U.S. Radiologic technologists | Q57250667 | ||
| Papillary Thyroid Cancer and Polymorphic Variants in TSHR- and RET-Related Genes: a Nested Case-Control Study within a Cohort of U.S. Radiologic Technologists | Q57250678 | ||
| Polymorphisms in Apoptosis- and Proliferation-Related Genes, Ionizing Radiation Exposure, and Risk of Breast Cancer among U.S. Radiologic Technologists | Q57250681 | ||
| Sequence Variant Discovery in DNA Repair Genes from Radiosensitive and Radiotolerant Prostate Brachytherapy Patients | Q58051408 | ||
| Second Cancers Among 104760 Survivors of Cervical Cancer: Evaluation of Long-Term Risk | Q58410884 | ||
| Long-Term Solid Cancer Risk Among 5-Year Survivors of Hodgkin's Lymphoma | Q58410899 | ||
| Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors | Q58411051 | ||
| Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease | Q58411256 | ||
| Treatment-Associated Leukemia Following Testicular Cancer | Q58411442 | ||
| Second primary cancer after treatment for cervical cancer. An international cancer registries study | Q58411688 | ||
| Late Cardiac Mortality and Morbidity in Early-Stage Breast Cancer Patients After Breast-Conservation Treatment | Q59420903 | ||
| Report from the Rockefellar Foundation Sponsored International Workshop on reducing mortality and improving quality of life in long-term survivors of Hodgkin's disease: July 9-16, 2003, Bellagio, Italy | Q62096610 | ||
| Risk of Second Malignancy After Non-Hodgkin's Lymphoma: A British Cohort Study | Q62583513 | ||
| Cancer in the contralateral breast after radiotherapy for breast cancer | Q68062077 | ||
| Risk of leukemia after chemotherapy and radiation treatment for breast cancer | Q68137055 | ||
| Bone sarcomas linked to radiotherapy and chemotherapy in children | Q68768068 | ||
| Second cancers following non-Hodgkin's lymphoma | Q70118111 | ||
| Factors affecting late mortality from heart disease after treatment of Hodgkin's disease | Q70508903 | ||
| The Late Appearance of Chronic Pericardial Disease in Patients Treated by Radiotherapy for Hodgkin's Disease | Q70751208 | ||
| Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma | Q70898773 | ||
| Second cancers following radiotherapy for cervical cancer | Q72052306 | ||
| Relationship of leukemia risk to radiation dose following cancer of the uterine corpus | Q72138140 | ||
| Risk of leukemia following treatment for non-Hodgkin's lymphoma | Q72198411 | ||
| Acute basophilic leukemia and acute eosinophilic leukemia after therapy for non-Hodgkin's lymphoma | Q72648340 | ||
| Cardiac disease following treatment of Hodgkin's disease in children and adolescents | Q72790321 | ||
| Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma | Q73102809 | ||
| Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors | Q34488758 | ||
| Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study. | Q34528330 | ||
| Secondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. | Q34575967 | ||
| Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia | Q34610676 | ||
| Coronary artery findings after left-sided compared with right-sided radiation treatment for early-stage breast cancer. | Q34651752 | ||
| Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study | Q34667727 | ||
| Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma | Q34721817 | ||
| Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer | Q34737424 | ||
| Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk | Q34743299 | ||
| Biology, risk stratification, and therapy of pediatric acute leukemias: an update | Q34764504 | ||
| Occurrence of multiple subsequent neoplasms in long-term survivors of childhood cancer: a report from the childhood cancer survivor study | Q35170216 | ||
| The Swedish Council on Technology Assessment in Health Care (SBU) Systematic Overview of Radiotherapy for Cancer including a Prospective Survey of Radiotherapy Practice in Sweden 2001--Summary and Conclusions | Q35574838 | ||
| Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort | Q35699184 | ||
| Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma | Q36064495 | ||
| Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer | Q36157947 | ||
| Radiation-induced sarcomas after radiotherapy for breast carcinoma: a large-scale single-institution review | Q36175987 | ||
| Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations | Q36359653 | ||
| Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party | Q36384739 | ||
| A system for stereotactic radiosurgery with a linear accelerator | Q36444705 | ||
| Intensity-modulated radiation therapy, protons, and the risk of second cancers | Q36450877 | ||
| Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease | Q36493565 | ||
| Effects of dietary antioxidant supplementation on the development of malignant lymphoma and other neoplastic lesions in mice exposed to proton or iron-ion radiation | Q36661328 | ||
| Risk of second malignancies after adjuvant radiotherapy for breast cancer: a large-scale, single-institution review | Q36767284 | ||
| From new frontiers to new standards of practice: advances in radiotherapy planning and delivery | Q36886968 | ||
| Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy | Q36915223 | ||
| Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy | Q36934353 | ||
| Breast cancer risk polymorphisms and interaction with ionizing radiation among U.S. radiologic technologists | Q36973531 | ||
| Solid cancers after allogeneic hematopoietic cell transplantation | Q37082013 | ||
| Long-term cardiac and pulmonary complications of cancer therapy | Q37131542 | ||
| The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research | Q37181672 | ||
| Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study | Q37196974 | ||
| Genome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibility | Q37209075 | ||
| Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer | Q37228497 | ||
| Dose to normal tissues outside the radiation therapy patient's treated volume: a review of different radiation therapy techniques | Q37292268 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cancer | Q12078 |
| adaptive radiation therapy | Q180507 | ||
| cardiovascular disease | Q389735 | ||
| P304 | page(s) | 357-370 | |
| P577 | publication date | 2012-02-06 | |
| P1433 | published in | Journal of the National Cancer Institute | Q400279 |
| P1476 | title | Second malignant neoplasms and cardiovascular disease following radiotherapy | |
| P478 | volume | 104 |
| Q49458449 | A case of peritoneal malignant mesothelioma following radiation therapy for cervical cancer |
| Q47947282 | AAPM TG 158: Measurement and calculation of doses outside the treated volume from external-beam radiation therapy |
| Q38766229 | Accelerated Premalignant Polyposis and Second Colon Cancers: Incriminating Immunosuppression, Radiotherapy, and Systemic Chemotherapy Agents |
| Q38093037 | Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors |
| Q42717147 | App for aftercare |
| Q48215134 | Association of Radon Background and Total Background Ionizing Radiation with Alzheimer's Disease Deaths in U.S. States |
| Q34220076 | Biological Effects of Space Radiation and Development of Effective Countermeasures |
| Q38769860 | Biological measures to minimize the risk of radiotherapy-associated second cancer: A research perspective |
| Q34611664 | Body mass index and risk of second obesity-associated cancers after colorectal cancer: a pooled analysis of prospective cohort studies |
| Q40282055 | Breast Cancer Screening in Patients With Newly Diagnosed Lung and Colorectal Cancer: A Population-Based Study of Utilization |
| Q42547157 | Cancer treatment-related cardiotoxicity: current state of knowledge and future research priorities |
| Q36732654 | Cardiac Outcomes in Adult Survivors of Childhood Cancer Exposed to Cardiotoxic Therapy: A Cross-sectional Study |
| Q26851957 | Cardiac toxicity in cancer survivors |
| Q36090962 | Cardiovascular Disease Mortality After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study |
| Q59459112 | Cardiovascular co-morbidity in cancer patients: the role of psychological distress |
| Q37632162 | Cardiovascular sequelae in long-term survivors of young peoples' cancer: a linked cohort study |
| Q38209876 | Cardiovascular sequelae of radiation therapy |
| Q64389555 | Charged-Iron-Particles Found in Galactic Cosmic Rays are Potent Inducers of Epithelial Ovarian Tumors |
| Q36057728 | Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics |
| Q35890681 | Chronic Intake of Japanese Sake Mediates Radiation-Induced Metabolic Alterations in Mouse Liver |
| Q37663082 | Computational methods using genome-wide association studies to predict radiotherapy complications and to identify correlative molecular processes |
| Q53089768 | Connexin-43 regulates p38-mediated cell migration and invasion induced selectively in tumour cells by low doses of γ-radiation in an ERK-1/2-independent manner. |
| Q64970171 | DNA Methylation in Radiation-Induced Carcinogenesis: Experimental Evidence and Clinical Perspectives. |
| Q38725967 | Different Sequences of Fractionated Low-Dose Proton and Single Iron-Radiation-Induced Divergent Biological Responses in the Heart |
| Q38688797 | Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin Lymphoma? |
| Q34360588 | Does this chest radiograph belong to a survivor of childhood cancer? Radiographic findings suggesting previous treatment for childhood cancer - a review. |
| Q61447945 | Dysfunctional endothelial progenitor cells in patients with Hodgkin's lymphoma in complete remission |
| Q52715715 | Early-stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long-term patient outcomes. |
| Q92288309 | Enhancing Career Paths for Tomorrow's Radiation Oncologists |
| Q26766890 | Evolving Clinical Cancer Radiotherapy: Concerns Regarding Normal Tissue Protection and Quality Assurance |
| Q42467636 | GH replacement therapy and second neoplasms in adult survivors of childhood cancer: a retrospective study from a single institution |
| Q41852251 | Immunogenic cell death in radiation therapy |
| Q37087450 | Impact of human papillomavirus on oropharyngeal cancer biology and response to therapy: implications for treatment |
| Q92581632 | Incidence, Risk Factors, and Mortality Associated With Second Malignant Neoplasms Among Survivors of Adolescent and Young Adult Cancer |
| Q35677701 | Increased stomach cancer risk following radiotherapy for testicular cancer |
| Q38220908 | Ionizing radiation-induced oxidative stress, epigenetic changes and genomic instability: the pivotal role of mitochondria |
| Q40148445 | Late mortality, secondary malignancy and hospitalisation in teenage and young adult survivors of Hodgkin lymphoma: report of the Childhood/Adolescent/Young Adult Cancer Survivors Research Program and the BC Cancer Agency Centre for Lymphoid Cancer |
| Q55348054 | Long term deficiency of vitamin D in germ cell testicular cancer survivors. |
| Q38555787 | Long-term Morbidity of Testicular Cancer Treatment |
| Q58775872 | Long-term risk of cardiovascular mortality in lymphoma survivors: A systematic review and meta-analysis |
| Q47239998 | Long-term toxicity of cisplatin in germ-cell tumor survivors. |
| Q38952121 | Management of stage I testicular germ cell tumours. |
| Q91660940 | MicroRNAs as Biomarkers for Germ Cell Tumors |
| Q28389573 | Mutational signatures of ionizing radiation in second malignancies |
| Q35780174 | Outcomes in stage I testicular seminoma: a population-based study of 9193 patients |
| Q38638121 | Postirradiation Leiomyosarcoma of Rectum Presenting as a Polyp: Case Report and Review of the Literature |
| Q34162911 | Prediction of the location and size of the stomach using patient characteristics for retrospective radiation dose estimation following radiotherapy |
| Q50103903 | Predictors of enrollment in individual- and couple-based lifestyle intervention trials for cancer survivors |
| Q36920190 | Protocol for Care After Lymphoma (CALy) trial: a phase II pilot randomised controlled trial of a lymphoma nurse-led model of survivorship care |
| Q36524125 | Proton therapy versus photon radiation therapy for the management of a recurrent desmoid tumor of the right flank: a case report |
| Q36736612 | Radiotherapy-induced malignancies: review of clinical features, pathobiology, and evolving approaches for mitigating risk |
| Q45945127 | Review of Session 7: non-cancer risk. |
| Q30873170 | Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United States |
| Q39965770 | Risk of colorectal cancer after the diagnosis of prostate cancer: A population-based study |
| Q30545002 | Risk of subsequent cancer following a primary CNS tumor |
| Q36538754 | Second malignant neoplasms following radiotherapy |
| Q92978424 | Secondary cancer risk after radiation therapy for breast cancer with different radiotherapy techniques |
| Q38221521 | Secondary malignancies in pediatric cancer survivors: perspectives and review of the literature |
| Q95822336 | Solid and Hematologic Neoplasms After Testicular Cancer: A US Population-Based Study of 24 900 Survivors |
| Q37227682 | Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study |
| Q43077330 | Subclinical ventricular dysfunction detected by speckle-tracking two years after use of anthracycline |
| Q35648976 | Synthesis and biological evaluation of benzo[d][1,3]dioxol-5-yl chalcones as antiproliferating agents |
| Q35577959 | Tenascin-C: Exploitation and collateral damage in cancer management |
| Q36077772 | The Prediction of Radiotherapy Toxicity Using Single Nucleotide Polymorphism-Based Models: A Step Toward Prevention |
| Q38543470 | The concept and evolution of involved site radiation therapy for lymphoma |
| Q36135801 | The diverse and complex roles of radiation on cancer treatment: therapeutic target and genome maintenance |
| Q34582650 | The impact of protocol assignment for older adolescents with hodgkin lymphoma |
| Q38611096 | Therapy-related myeloid neoplasms: when genetics and environment collide |
| Q55162138 | Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors. |
| Q42847992 | Trial Watch: Anticancer radioimmunotherapy |
| Q37308207 | Trial Watch: Immunotherapy plus radiation therapy for oncological indications |
| Q43104064 | Trial Watch: Radioimmunotherapy for oncological indications |
Search more.